Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Inotiv, Inc. (NOTVQ)
USD0.02
+0.01 (+44.62%)
US PNK Healthcare Medical - Diagnostics & Research
Address
2701 Kent Avenue 47906
West Lafayette, IN, US
West Lafayette, IN, US
CEO
Robert W. Leasure Jr.
Website
inotiv.com
IPO
1997-11-25
CIK 720154 ISIN US45783Q1004
Also trades on
NASDAQ Capital Market · NOTV (USD)
Other OTC · NOTVQ (USD)
Description
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company's BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana. On June 3, 2026, Inotiv, Inc. along with its affiliates filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.02
+0.01 (+44.62%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
20M
Beta
3.92
Float Shares
32.32M
Free Float %
92.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -50.00% | -75.37% | -96.33% | -96.63% | -98.50% | -98.22% | -99.51% | -99.80% | -99.97% | -99.01% | -99.88% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (3 ratings, all time)
Buy
Price Targets & DCF
Current price
0.02
Low
3.00
+15,857.4%
Consensus
5.67
+30,059.6%
Median
6.00
+31,814.9%
High
8.00
+42,453.2%
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-06 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | -1 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 1 |
3.00
+15,857.4%
|
| All Time | 5 |
6.20
+32,878.7%
|
Quality scores
Altman Z-Score
-1.55
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Diagnostics & Research: +7.9%+4.5% Q1'26: -5.4% (vs Q1'25)
-
EPS growth Medical - Diagnostics & Research: +30.8%+49.6% ★ Q1'26: -113.6% (vs Q1'25)
-
FCF margin FCF growth · Medical - Diagnostics & Research: +32.2%-5.9% Q1'26: -2.7% (vs Q1'25)
-
EBIT margin Medical - Diagnostics & Research: +9.6%-6.1% Q1'26: -13.9% (vs Q1'25)
-
ROIC Medical - Diagnostics & Research: +5.2%-5.1% Q1'26: -11.5% (vs Q1'25)
-
Share dilution Medical - Diagnostics & Research: 0.0%+25.3% Q1'26: +1.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Diagnostics & Research: -0.13×20.35× Q1'26: -53.25× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Sep 2024 actual |
Sep 2025 actual |
Sep 2026 1 Rev. Ana. 1 EPS Ana. |
Sep 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|
| Revenue |
490.74M
est: 477.25M (+2.8%)
|
513.02M
est: 510.50M (+0.5%)
|
529.53M
529.53M – 529.53M
+3.7% YoY
|
558.22M
558.22M – 558.22M
+5.4% YoY
|
| EBITDA |
-26.76M
est: -36.31M (+26.3%)
|
24.75M
est: -38.83M (+163.7%)
|
-40.28M
-40.28M – -40.28M
-3.7% YoY
|
-42.46M
-42.46M – -42.46M
-5.4% YoY
|
| EBIT |
-83.88M
est: -83.60M (-0.3%)
|
-31.18M
est: -89.42M (+65.1%)
|
-92.76M
-92.76M – -92.76M
-3.7% YoY
|
-97.78M
-97.78M – -97.78M
-5.4% YoY
|
| Net Income |
-108.45M
est: -143.92M (+24.7%)
|
-68.63M
est: -75.94M (+9.6%)
|
-73.50M
-73.50M – -73.50M
+3.2% YoY
|
-58.74M
-58.74M – -58.74M
+20.1% YoY
|
| SGA |
97.92M
est: 110.81M (-11.6%)
|
92.24M
est: 118.53M (-22.2%)
|
122.95M
122.95M – 122.95M
+3.7% YoY
|
129.61M
129.61M – 129.61M
+5.4% YoY
|
| EPS |
-4.19
est: -4.44 (+5.5%)
|
-2.11
est: -2.34 (+9.8%)
|
-2.27
-2.27 – -2.27
+3.2% YoY
|
-1.81
-1.81 – -1.81
+20.1% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-18 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-06-10 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-06-09 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-06-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-06-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-06-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-06-03 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-06-02 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-06-01 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-26 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-19 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-18 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-1.63M
OE per share TTM
-0.05
Owner's Yield
-362.58%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
44.4%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
2
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.25
Bearish
Ratio by volume
0.07
Bearish
Buys
1
Sells
4
Shares acquired
10.0K
Shares disposed
135.1K
Cash buys
—
Cash sales
4.00
Net activity
-125,114
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | Young John T. Jr. | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-05-14 | DAVIS EUGENE I | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-02-17 | Taylor Beth A. | Officer | S-Sale | D | Common Stock | 2,888 | 0.29 | 845.90 | 145,480 | D | ↗ |
| 2026-02-17 | Sagartz John E | Officer | S-Sale | D | Common Stock | 2,119 | 0.29 | 616.21 | 735,697 | D | ↗ |
| 2026-02-17 | Leasure Robert Jr. | Director / Officer | S-Sale | D | Common Stock | 16,810 | 0.30 | 5.0K | 1,256,215 | D | ↗ |
| 2026-02-02 | Leasure Robert Jr. | Director / Officer | S-Sale | D | Common Stock | 113,297 | 0.50 | 57.0K | 1,273,025 | D | ↗ |
| 2026-01-15 | Castetter Andrea | Officer | A-Award | A | Employee Stock Option (right to buy) | 10,000 | 0.60 | 6.0K | 10,000 | D | ↗ |
| 2025-12-01 | Neff R Matthew | Director | S-Sale | D | Common Stock | 2,000 | 0.89 | 1.8K | 151,102 | D | ↗ |
| 2025-11-03 | Neff R Matthew | Director | S-Sale | D | Common Stock | 2,000 | 1.24 | 2.5K | 153,102 | D | ↗ |
| 2025-10-24 | Neff R Matthew | Director | M-Exempt | D | Director Stock Option (right to buy) | 10,000 | 1.94 | 19.4K | 0 | D | ↗ |
| 2025-10-01 | Neff R Matthew | Director | S-Sale | D | Common Stock | 2,000 | 1.43 | 2.9K | 145,102 | D | ↗ |
| 2025-09-02 | Neff R Matthew | Director | S-Sale | D | Common Stock | 2,000 | 1.67 | 3.3K | 147,102 | D | ↗ |
| 2025-08-01 | Neff R Matthew | Director | S-Sale | D | Common Stock | 2,000 | 1.91 | 3.8K | 149,102 | D | ↗ |
| 2025-07-01 | Neff R Matthew | Director | S-Sale | D | Common Stock | 2,000 | 1.81 | 3.6K | 151,102 | D | ↗ |
| 2025-06-02 | Neff R Matthew | Director | S-Sale | D | Common Stock | 2,000 | 2.62 | 5.2K | 153,102 | D | ↗ |
| 2025-04-01 | Coelho Mary Theresa | Director | S-Sale | D | Common Stock | 5,500 | 2.35 | 12.9K | 74,303 | D | ↗ |
| 2025-03-14 | Taylor Beth | Officer | A-Award | A | Common Stock | 40,000 | 0.00 | — | 148,368 | D | ↗ |
| 2025-03-14 | Sagartz John E | Director / Officer | A-Award | A | Common Stock | 30,000 | 0.00 | — | 737,816 | D | ↗ |
| 2025-03-14 | Neff R Matthew | Director | A-Award | A | Common Stock | 39,392 | 0.00 | — | 155,102 | D | ↗ |
| 2025-03-14 | Leasure Robert Jr. | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 429,730 | 2.79 | 1.20M | 429,730 | D | ↗ |
| 2025-03-14 | Landman David | Director | A-Award | A | Common Stock | 39,392 | 0.00 | — | 216,243 | D | ↗ |
| 2025-03-14 | Krupp Jeffrey Arthur | Officer | A-Award | A | Common Stock | 25,000 | 0.00 | — | 53,557 | D | ↗ |
| 2025-03-14 | Harrington Michael J | Director | A-Award | A | Common Stock | 39,392 | 0.00 | — | 76,892 | D | ↗ |
| 2025-03-14 | Hardy Adrian | Officer | A-Award | A | Common Stock | 25,000 | 0.00 | — | 58,420 | D | ↗ |
| 2025-03-14 | Freeman Jeffrey Brennan | Officer | A-Award | A | Common Stock | 15,000 | 0.00 | — | 42,478 | D | ↗ |
| 2025-03-14 | Coelho Mary Theresa | Director | A-Award | A | Common Stock | 39,392 | 0.00 | — | 79,803 | D | ↗ |
| 2025-03-14 | Castetter Andrea | Officer | A-Award | A | Common Stock | 35,000 | 0.00 | — | 55,000 | D | ↗ |
| 2025-03-14 | Brown Nigel | Director | A-Award | A | Common Stock | 39,392 | 0.00 | — | 104,929 | D | ↗ |
| 2025-03-14 | Beattie John Gregory | Officer | A-Award | A | Common Stock | 25,000 | 0.00 | — | 186,761 | D | ↗ |
| 2025-02-21 | Taylor Beth | Officer | A-Award | A | Employee Stock Option (right to buy) | 6,500 | 4.21 | 27.3K | 6,500 | D | ↗ |
| 2025-02-21 | Sagartz John E | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 6,500 | 4.21 | 27.3K | 6,500 | D | ↗ |
| 2025-02-21 | Krupp Jeffrey Arthur | Officer | A-Award | A | Employee Stock Option (right to buy) | 6,500 | 4.21 | 27.3K | 6,500 | D | ↗ |
| 2025-02-21 | Hardy Adrian | Officer | A-Award | A | Employee Stock Option (right to buy) | 6,500 | 4.21 | 27.3K | 6,500 | D | ↗ |
| 2025-02-21 | Freeman Jeffrey Brennan | Officer | A-Award | A | Employee Stock Option (right to buy) | 3,750 | 4.21 | 15.8K | 3,750 | D | ↗ |
| 2025-02-21 | Castetter Andrea | Officer | A-Award | A | Employee Stock Option (right to buy) | 6,500 | 4.21 | 27.3K | 6,500 | D | ↗ |
| 2025-02-21 | Beattie John Gregory | Officer | A-Award | A | Employee Stock Option (right to buy) | 6,500 | 4.21 | 27.3K | 6,500 | D | ↗ |
| 2025-02-18 | Taylor Beth | Officer | S-Sale | D | Common Stock | 4,370 | 4.01 | 17.5K | 108,368 | D | ↗ |
| 2025-02-18 | Sagartz John E | Director / Officer | S-Sale | D | Common Stock | 2,113 | 3.94 | 8.3K | 707,816 | D | ↗ |
| 2025-02-18 | Leasure Robert Jr. | Director / Officer | S-Sale | D | Common Stock | 73,617 | 3.82 | 281.1K | 956,592 | D | ↗ |
| 2025-02-18 | Freeman Jeffrey Brennan | Officer | S-Sale | D | Common Stock | 1,339 | 4.05 | 5.4K | 27,478 | D | ↗ |
| 2025-02-03 | Krupp Jeffrey Arthur | Officer | S-Sale | D | Common Stock | 472 | 4.18 | 2.0K | 28,557 | D | ↗ |
| 2025-01-31 | Taylor Beth | Officer | S-Sale | D | Common Stock | 2,054 | 4.47 | 9.2K | 112,738 | D | ↗ |
| 2025-01-31 | Sagartz John E | Director / Officer | S-Sale | D | Common Stock | 2,118 | 4.48 | 9.5K | 709,929 | D | ↗ |
| 2025-01-31 | Leasure Robert Jr. | Director / Officer | S-Sale | D | Common Stock | 22,700 | 4.15 | 94.3K | 1,030,209 | D | ↗ |
| 2025-01-31 | Krupp Jeffrey Arthur | Officer | S-Sale | D | Common Stock | 2,036 | 4.48 | 9.1K | 29,029 | D | ↗ |
| 2025-01-15 | Castetter Andrea | Officer | A-Award | A | Employee Stock Option (right to buy) | 10,000 | 4.20 | 42.0K | 10,000 | D | ↗ |
| 2024-12-19 | Landman David | Director | P-Purchase | A | Common Stock | 23,529 | 4.25 | 100.0K | 176,851 | D | ↗ |
| 2024-12-10 | Brown Nigel | Director | P-Purchase | A | Common Stock | 7,500 | 4.26 | 32.0K | 65,537 | D | ↗ |
| 2024-12-10 | Beattie John Gregory | Officer | P-Purchase | A | Common Stock | 30,000 | 4.75 | 142.5K | 161,761 | D | ↗ |
| 2024-12-06 | Landman David | Director | P-Purchase | A | Common Stock | 100,000 | 4.14 | 414.0K | 153,322 | D | ↗ |
| 2024-12-06 | Harrington Michael J | Director | P-Purchase | A | Common Stock | 10,000 | 3.98 | 39.8K | 37,500 | D | ↗ |
| 2024-08-10 | Taylor Beth | Officer | A-Award | A | Employee Stock Option (right to buy) | 20,000 | 1.61 | 32.2K | 20,000 | — | ↗ |
| 2024-08-10 | Sagartz John E | Director / Officer | A-Award | A | Common Stock | 20,000 | 0.00 | — | 712,047 | — | ↗ |
| 2024-08-10 | Neff R Matthew | Director | A-Award | A | Common Stock | 27,500 | 0.00 | — | 115,710 | — | ↗ |
| 2024-08-10 | Leasure Robert Jr. | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 300,000 | 1.61 | 483.0K | 300,000 | — | ↗ |
| 2024-08-10 | Landman David | Director | A-Award | A | Common Stock | 27,500 | 0.00 | — | 53,322 | — | ↗ |
| 2024-08-10 | Krupp Jeffrey Arthur | Officer | A-Award | A | Employee Stock Option (right to buy) | 20,000 | 1.61 | 32.2K | 20,000 | — | ↗ |
| 2024-08-10 | Harrington Michael J | Director | A-Award | A | Common Stock | 27,500 | 0.00 | — | 27,500 | — | ↗ |
| 2024-08-10 | Hardy Adrian | Officer | A-Award | A | Common Stock | 20,000 | 0.00 | — | 33,420 | — | ↗ |
| 2024-08-10 | Freeman Jeffrey Brennan | Officer | A-Award | A | Employee Stock Option (right to buy) | 20,000 | 1.61 | 32.2K | 20,000 | — | ↗ |
| 2024-08-10 | Coelho Mary Theresa | Director | A-Award | A | Common Stock | 27,500 | 0.00 | — | 40,411 | — | ↗ |
| 2024-08-10 | Castetter Andrea | Officer | A-Award | A | Employee Stock Option (right to buy) | 20,000 | 1.61 | 32.2K | 20,000 | — | ↗ |
| 2024-08-10 | Brown Nigel | Director | A-Award | A | Common Stock | 27,500 | 0.00 | — | 58,037 | — | ↗ |
| 2024-08-10 | Beattie John Gregory | Officer | A-Award | A | Employee Stock Option (right to buy) | 20,000 | 1.61 | 32.2K | 20,000 | — | ↗ |
| 2024-06-04 | Hardy Adrian | Officer | — | D | Employee Stock Option (right to buy) | 2,188 | 3.09 | 6.8K | 0 | — | ↗ |
| 2024-03-14 | Harrington Michael J | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-01-15 | Castetter Andrea | Officer | A-Award | A | Employee Stock Option (right to buy) | 10,000 | 4.17 | 41.7K | 10,000 | — | ↗ |
| 2023-12-15 | Taylor Beth | Officer | A-Award | A | Employee Stock Option (right to buy) | 6,250 | 3.09 | 19.3K | 6,250 | — | ↗ |
| 2023-12-15 | Sagartz John E | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 6,250 | 3.09 | 19.3K | 6,250 | — | ↗ |
| 2023-12-15 | Krupp Jeffrey Arthur | Officer | A-Award | A | Employee Stock Option (right to buy) | 3,750 | 3.09 | 11.6K | 3,750 | — | ↗ |
| 2023-12-15 | Garrett Michael | Officer | A-Award | A | Employee Stock Option (right to buy) | 10,000 | 3.09 | 30.9K | 10,000 | — | ↗ |
| 2023-12-15 | Freeman Jeffrey Brennan | Officer | A-Award | A | Employee Stock Option (right to buy) | 4,375 | 3.09 | 13.5K | 4,375 | — | ↗ |
| 2023-12-15 | Beattie John Gregory | Officer | A-Award | A | Employee Stock Option (right to buy) | 7,500 | 3.09 | 23.2K | 7,500 | — | ↗ |
| 2023-12-14 | Garrett Michael | Officer | P-Purchase | A | Common Stock | 5,000 | 2.83 | 14.1K | 16,467 | — | ↗ |
| 2023-12-14 | Beattie John Gregory | Officer | P-Purchase | A | Common Stock | 47,966 | 3.12 | 149.8K | 111,761 | — | ↗ |
| 2023-10-23 | Castetter Andrea | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-10-17 | Coelho Mary Theresa | Director | A-Award | A | Common Stock | 12,911 | 0.00 | — | 12,911 | — | ↗ |
| 2023-10-16 | Coelho Mary Theresa | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-04-01 | Neff R Matthew | Director | A-Award | A | Common Stock | 25,822 | 0.00 | — | 88,210 | — | ↗ |
| 2023-04-01 | Landman David | Director | A-Award | A | Common Stock | 25,822 | 0.00 | — | 25,822 | — | ↗ |
| 2023-04-01 | Johnson Richard Allen | Director | A-Award | A | Common Stock | 25,822 | 0.00 | — | 97,780 | — | ↗ |
| 2023-04-01 | Davis Gregory Cole | Director | A-Award | A | Common Stock | 25,822 | 0.00 | — | 67,780 | — | ↗ |
| 2023-04-01 | Brown Nigel | Director | A-Award | A | Common Stock | 25,822 | 0.00 | — | 30,537 | — | ↗ |
| 2023-03-30 | Beraldi Fernanda | Officer | A-Award | A | Common Stock | 2,500 | 0.00 | — | 7,840 | — | ↗ |
| 2023-03-14 | Sagartz John E | Director / Officer | P-Purchase | A | Common Stock | 5,100 | 4.91 | 25.0K | 692,047 | — | ↗ |
| 2023-02-22 | Beattie John Gregory | Officer | P-Purchase | A | Common Stock | 5,000 | 6.99 | 35.0K | 63,795 | — | ↗ |
| 2023-02-17 | Taylor Beth | Officer | A-Award | A | Common Stock | 5,000 | 0.00 | — | 94,792 | — | ↗ |
| 2023-02-17 | Leasure Robert Jr. | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 151,706 | 7.91 | 1.20M | 151,706 | — | ↗ |
| 2023-02-17 | Freeman Jeffrey Brennan | Officer | A-Award | A | Common Stock | 4,000 | 0.00 | — | 8,817 | — | ↗ |
| 2023-01-24 | Landman David | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-01-18 | Taylor Beth | Officer | A-Award | A | Common Stock | 5,917 | 0.00 | — | 89,792 | — | ↗ |
| 2023-01-18 | Sagartz John E | Officer | A-Award | A | Common Stock | 5,917 | 0.00 | — | 686,947 | — | ↗ |
| 2023-01-18 | Leasure Robert Jr. | Officer | A-Award | A | Common Stock | 59,172 | 0.00 | — | 693,703 | — | ↗ |
| 2023-01-18 | Krupp Jeffrey Arthur | Officer | A-Award | A | Common Stock | 5,000 | 0.00 | — | 11,065 | — | ↗ |
| 2023-01-18 | Garrett Michael | Officer | A-Award | A | Common Stock | 9,467 | 0.00 | — | 11,467 | — | ↗ |
| 2023-01-18 | Freeman Jeffrey Brennan | Officer | A-Award | A | Common Stock | 4,142 | 0.00 | — | 4,817 | — | ↗ |
| 2023-01-18 | Beraldi Fernanda | Officer | A-Award | A | Common Stock | 2,840 | 0.00 | — | 5,340 | — | ↗ |
| 2023-01-18 | Beattie John Gregory | Officer | A-Award | A | Common Stock | 7,101 | 0.00 | — | 58,795 | — | ↗ |
| 2023-01-17 | Krupp Jeffrey Arthur | Officer | — | D | Common Stock | 0 | 0.00 | — | 5,000 | — | ↗ |
| 2022-12-09 | Pitchford William D | Officer | S-Sale | D | Common Stock | 2,123 | 5.82 | 12.4K | 74,051 | — | ↗ |
| 2022-12-01 | Neff R Matthew | Director | S-Sale | D | Common Stock | 1,000 | 6.12 | 6.1K | 62,388 | — | ↗ |
| 2022-11-30 | BAKER ANDREW H | 10% Owner | J-Other | D | Common Shares | 488,256 | 0.00 | — | 1,806,690 | — | ↗ |
| 2022-11-01 | Neff R Matthew | Director | S-Sale | D | Common Stock | 500 | 21.12 | 10.6K | 63,888 | — | ↗ |
| 2022-10-25 | Freeman Jeffrey Brennan | Officer | — | D | Employee Stock Option (right to buy) | 2,000 | 34.69 | 69.4K | — | — | ↗ |
| 2022-10-17 | Neff R Matthew | Director | S-Sale | D | Common Stock | 1,000 | 19.10 | 19.1K | 64,388 | — | ↗ |
| 2022-04-15 | Beraldi Fernanda | Officer | A-Award | A | Employee Stock Option (right to buy) | 2,500 | 0.00 | — | 2,500 | — | ↗ |
| 2022-04-01 | Neff R Matthew | Director | A-Award | A | Common Stock | 4,275 | 0.00 | — | 65,388 | — | ↗ |
| 2022-04-01 | Johnson Richard Allen | Director | A-Award | A | Common Stock | 4,275 | 0.00 | — | 71,958 | — | ↗ |
| 2022-04-01 | Davis Gregory Cole | Director | A-Award | A | Common Stock | 4,275 | 0.00 | — | 41,958 | — | ↗ |
| 2022-04-01 | Cragg Scott | Director | A-Award | A | Common Stock | 4,275 | 0.00 | — | 4,715 | — | ↗ |
| 2022-04-01 | Brown Nigel | Director | A-Award | A | Common Stock | 4,275 | 0.00 | — | 4,715 | — | ↗ |
| 2022-03-31 | Beraldi Fernanda | Officer | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-03-17 | Leasure Robert Jr. | Director | A-Award | A | Common Shares | 275,000 | 0.00 | — | 634,531 | — | ↗ |
| 2022-03-15 | Harkness James | Officer | P-Purchase | A | Common Shares | 4,049 | 18.84 | 76.3K | 38,968 | — | ↗ |
| 2022-03-01 | Bibi Mark L | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-02-18 | Davis Gregory Cole | Director | P-Purchase | A | Common Shares | 1,250 | 21.12 | 26.4K | 37,683 | — | ↗ |
| 2022-02-17 | Sagartz John E | Director / Officer | P-Purchase | A | Common Shares | 2,506 | 19.95 | 50.0K | 681,030 | — | ↗ |
| 2022-02-17 | Leasure Robert Jr. | Director / Officer | P-Purchase | A | Common Shares | 5,000 | 23.03 | 115.1K | 285,216 | — | ↗ |
| 2022-02-17 | Davis Gregory Cole | Director | P-Purchase | A | Common Shares | 1,250 | 20.57 | 25.7K | 33,933 | — | ↗ |
| 2022-02-15 | Sagartz John E | Director / Officer | A-Award | A | Common Shares | 30,000 | 0.00 | — | 678,524 | — | ↗ |
| 2022-02-15 | Leasure Robert Jr. | Director / Officer | A-Award | A | Common Shares | 42,429 | 0.00 | — | 280,216 | — | ↗ |
| 2021-12-22 | Downing Philip A | Officer | S-Sale | D | Common Shares | 3,057 | 43.04 | 131.6K | 40,195 | — | ↗ |
| 2021-11-15 | BAKER ANDREW H | 10% Owner | J-Other | D | Common Shares | 359,033 | 0.00 | — | 2,294,946 | — | ↗ |
| 2021-11-05 | P2 Capital Partners, LLC | 10% Owner | — | I | Common Shares | 0 | 0.00 | — | 2,946,961 | — | ↗ |
| 2021-11-05 | Harkness James | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-11-05 | Hardy Adrian | Officer | — | D | Employee Stock Option (right to buy) | 355,780 | 9.93 | 3.53M | 0 | — | ↗ |
| 2021-11-05 | Garrett Michael | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-11-05 | Cragg Scott | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-11-05 | Brown Nigel | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-11-05 | Bibi Mark L | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-11-05 | BAKER ANDREW H | 10% Owner | — | I | Common Shares | 0 | 0.00 | — | 44,668 | — | ↗ |
| 2021-10-22 | Leasure Robert Jr. | Director / Officer | A-Award | A | Common Shares | 7,571 | 0.00 | — | 237,787 | — | ↗ |
| 2021-08-02 | Johnson Richard Allen | Director | M-Exempt | A | Common Shares | 10,000 | 1.94 | 19.4K | 67,683 | — | ↗ |
| 2021-06-07 | Sagartz John E | Director / Officer | P-Purchase | A | Common Shares | 1,742 | 28.70 | 50.0K | 648,524 | — | ↗ |
| 2021-05-28 | Sagartz John E | Director / Officer | P-Purchase | A | Common Shares | 2,012 | 24.78 | 49.9K | 646,782 | — | ↗ |
| 2021-05-27 | Sagartz John E | Director / Officer | P-Purchase | A | Common Shares | 5 | 24.00 | 120.00 | 644,770 | — | ↗ |
| 2021-05-07 | Sagartz John E | Director / Officer | A-Award | A | Common Shares | 880 | 0.00 | — | 644,765 | — | ↗ |
| 2021-05-07 | Leasure Robert Jr. | Director / Officer | A-Award | A | Common Shares | 3,667 | 0.00 | — | 230,216 | — | ↗ |
| 2021-05-07 | Flynn Joseph Earl | Officer | A-Award | A | Common Shares | 880 | 0.00 | — | 128,394 | — | ↗ |
| 2021-04-01 | Johnson Richard Allen | Director | A-Award | A | Common Shares | 2,683 | 0.00 | — | 42,683 | — | ↗ |
| 2021-04-01 | Davis Gregory Cole | Director | A-Award | A | Common Shares | 2,683 | 0.00 | — | 32,683 | — | ↗ |
| 2021-02-15 | Beattie John Gregory | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-03-09 | Taylor Beth | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-08-28 | Pitchford William D | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-06-07 | Leasure Robert Jr. | Director / Officer | P-Purchase | A | Common Stock | 7,500 | 1.98 | 14.9K | 105,000 | — | ↗ |
| 2019-02-20 | Flynn Joseph Earl | Officer | — | D | Employee Stock Option (right to buy) | 10,000 | 1.42 | 14.2K | 0 | — | ↗ |
| 2019-02-11 | Oakley Daniel Thomas | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-01-12 | Leasure Robert Jr. | Director / Officer | — | I | Common Stock | 0 | 0.00 | — | 26,100 | — | ↗ |
| 2018-07-02 | Sagartz Kimberly L | 10% Owner | — | I | Common Shares | 0 | 0.00 | — | 632,475 | — | ↗ |
| 2018-07-02 | Sagartz John E | Director / 10% Owner | — | I | Common Shares | 0 | 0.00 | — | 617,625 | — | ↗ |
| 2018-07-02 | SW Chrysalis, LLC | 10% Owner | — | D | Common Shares | 0 | 0.00 | — | 1,500,000 | — | ↗ |
| 2018-05-07 | Baim Michael | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2017-08-01 | Neff R Matthew | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2017-06-14 | Davis Gregory Cole | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2016-05-09 | Blumhoff Jill | Officer | — | D | Employee Stock Option (right to buy) | 10,000 | 1.70 | 17.0K | 0 | — | ↗ |
| 2015-12-10 | Perrow Wendy | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-09-15 | Dougherty Connie Leigh | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-06-09 | Potrzebowski Jeffrey | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-06-02 | Bourdage James Sevall | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-01-25 | Merrill R. Osheroff | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2013-05-08 | Rohde-Johnson Candace A | Director / Officer | — | D | Employee Stock Option (right to buy) | 500 | 1.40 | 700.00 | 0 | — | ↗ |
| 2013-05-08 | Downing Philip A | Officer | — | D | Common Stock | 0 | 0.00 | — | 4,000 | — | ↗ |
| 2012-05-09 | Johnson Richard Allen | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2012-03-30 | Lemke Jacqueline M | Officer | — | D | Common Stock | 0 | 0.00 | — | 1,000 | — | ↗ |
| 2012-03-15 | Payne Lori | Officer | — | D | Option to Purchase Common Shares | 5,000 | 5.74 | 28.7K | 0 | — | ↗ |
| 2011-09-20 | Devine John P | Officer | — | D | Common Shares | 0 | 0.00 | — | 100 | — | ↗ |
| 2011-07-29 | Landis John B. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2011-05-11 | Costa Brava Partnership III LP | 10% Owner | — | D | Class B Warrants to Purchase Common Stock | 250,000 | 2.00 | 500.0K | 0 | — | ↗ |
| 2010-08-18 | Hidalgo Alberto F Jr | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2010-04-15 | Hodges Kathleen | Officer | — | D | Option to Buy Common Shares | 5,000 | 5.09 | 25.5K | 0 | — | ↗ |
| 2010-01-26 | Sullivan A. Charlene | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2009-11-12 | Landis John B. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2009-10-08 | OMACHINSKI DAVID L | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2008-12-01 | Chilton Anthony S | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2008-10-01 | BREWER JON | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2007-11-15 | Cordova Emilio | Officer | — | I | Common Stock | 0 | 0.00 | — | 100 | — | ↗ |
| 2007-05-18 | Boulet Larry Steven | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2005-08-01 | Shepperd Richard M | Officer | — | D | Common Stock | 0 | 0.00 | — | 750 | — | ↗ |
| 2005-08-01 | CHAIT EDWARD | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2004-08-19 | DOSTER GARYL W | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2004-06-30 | DANIELS LESLIE B | Director | — | D | 6% Subordinated Convertible Note | 31,165 | 16.00 | 498.6K | 0 | — | ↗ |
| 2004-03-30 | COX MICHAEL R | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2004-02-19 | CRABB DAVID W | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2000-01-01 | SILVON MICHAEL P | Officer | — | I | Common Shares | 0 | 0.00 | — | 500 | — | ↗ |
| 1999-12-11 | SILVON MICHAEL P | Officer | — | D | Stock Options (right to buy common stock) | 2,000 | 4.25 | 8.5K | 0 | — | ↗ |
| 1998-11-25 | SILVON MICHAEL P | Officer | — | D | Stock Options (right to buy common stock) | 2,000 | 8.00 | 16.0K | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-16.0K
Shares Outstanding
34.89M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2012 | Anthony S. Chilton, Ph.D., President, Chief Executive Officer; Director Michael R. Cox, Vice President, Finance and Chief Financial Officer | 194.5K | — | — | 27.9K | — | 203.5K | 426.0K | 6.55% | ↗ |
| 2 | 2012 | Michael R. Cox, Vice President, Finance and Chief Financial Officer | 82.5K | — | — | — | — | 199.3K | 281.8K | 0.00% | ↗ |
| 3 | 2012 | Jacqueline M. Lemke, Interim President & Chief Executive Officer, Chief Financial Officer | 101.9K | 31.3K | — | 139.5K | — | — | 272.7K | 51.16% | ↗ |
| 4 | 2012 | Lori Payne, Vice President, Bioanalytical Services | 150.5K | 10.0K | — | 22.3K | — | 17.3K | 200.1K | 11.15% | ↗ |
| 5 | 2012 | John P. Devine, Jr., Vice President, Toxicology Anthony S. Chilton, Ph.D., President, Chief Executive Officer; Director | 145.0K | — | — | — | — | — | 145.0K | 0.00% | ↗ |
| 6 | 2011 | Michael R. Cox, Vice President, Finance and Chief Financial Officer | 254.3K | 69.9K | — | 46.3K | — | 49.5K | 420.0K | 11.03% | ↗ |
| 7 | 2011 | John P. Devine, Jr., Vice President, Toxicology Anthony S. Chilton, Ph.D., President, Chief Executive Officer; Director | 254.3K | 69.9K | — | 46.3K | — | 49.5K | 420.0K | 11.03% | ↗ |
| 8 | 2011 | Anthony S. Chilton, Ph.D., President, Chief Executive Officer; Director Michael R. Cox, Vice President, Finance and Chief Financial Officer | 165.0K | 20.0K | — | — | — | — | 185.0K | 0.00% | ↗ |
| 9 | 2011 | Alberto Hidalgo, Vice President, Business Development and Marketing | 165.0K | 20.0K | — | — | — | — | 185.0K | 0.00% | ↗ |
| 10 | 2010 | Anthony S. Chilton, Director Michael R. Cox, Vice President, Finance and Chief Financial Officer | 227.2K | 32.4K | — | 121.1K | — | 28.7K | 409.4K | 29.58% | ↗ |
| 11 | 2010 | Anthony S. Chilton, Ph.D., President, Chief Executive Officer; Director | 227.2K | 32.4K | — | 121.1K | — | 28.7K | 409.4K | 29.58% | ↗ |
| 12 | 2010 | Richard M. Shepperd, President & Chief Executive Officer | 90.0K | — | — | — | — | 130.0K | 220.0K | 0.00% | ↗ |
| 13 | 2010 | Michael R. Cox, Vice President, Finance and Chief Financial Officer | 165.0K | — | — | 22.8K | — | — | 187.8K | 12.14% | ↗ |
| 14 | 2010 | Alberto Hidalgo, Vice President, Business Development and Marketing | 19.3K | — | — | 25.2K | — | — | 44.5K | 56.64% | ↗ |
| 15 | 2009 | Richard M. Shepperd, President & Chief | 285.0K | — | — | — | — | 9.0K | 297.0K | 0.00% | ↗ |
| 16 | 2009 | Anthony S. Chilton, Director Michael R. Cox, Vice President, Finance and Chief Financial Officer | 165.0K | — | — | — | — | — | 166.9K | 0.00% | ↗ |
| 17 | 2008 | Finance and Chief Financial Officer Edward M. Chait, Ph.D., | 165.0K | 25.0K | — | 28.0K | — | — | 220.0K | 12.72% | ↗ |
| 18 | 2007 | Richard M. Shepperd, President & Chief Executive Officer; Director | 420.0K | 4.00 | — | 5.00 | — | 6.00 | 865.1K | 0.00% | ↗ |
| 19 | 2007 | Richard M. Shepperd, President & Chief | 420.0K | 295.0K | — | 141.3K | — | 8.8K | 865.1K | 16.33% | ↗ |
| 20 | 2007 | Peter T. Kissinger, Ph.D, Chairman of the Board and Chief Scientific Officer | 117.3K | — | — | — | — | 3.00 | 330.1K | 0.00% | ↗ |
| 21 | 2007 | Edward M. Chait, Ph.D., Vice President | 150.0K | 35.0K | — | 15.5K | — | — | 204.0K | 7.60% | ↗ |
| 22 | 2007 | Finance and Chief Financial Officer Edward M. Chait, Ph.D., | 150.0K | 35.0K | — | 15.5K | — | — | 204.0K | 7.60% | ↗ |
| 23 | 2007 | Michael R. Cox, Vice President, Finance and Chief Financial Officer | 153.0K | 40.0K | — | 6.2K | — | — | 200.8K | 3.11% | ↗ |
| 24 | 2007 | Ronald E. Shoup, Ph.D., Chief Operating Officer, BASi Contract Research Services | 135.4K | — | — | 25.6K | — | — | 164.9K | 15.50% | ↗ |
| 25 | 2007 | Candice B. Kissinger, Senior Vice President, Research; Secretary and Director | 120.4K | — | — | — | — | — | 122.6K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Robert W. Leasure Jr. | President, Chief Executive Officer & Director | 810.0K | male |
| Beth A. Taylor | EVP & CFO | 417.3K | female |
| John E. Sagartz DiplomateACVP | Chief Strategy Officer & Director | 406.3K | — |
| Andrea Castetter | EVice President of General Counsel & Corporate Secretary and Chief Compliance Office | 392.2K | female |
| Adrian Hardy | Chief Commercial Officer | 382.5K | — |
| Jeffrey Arthur Krupp | Chief Human Resources Officer | — | male |
| John Gregory Beattie | Chief Operating Officer of DSA | — | male |
| Lizanne Muller | Group President of RMS | — | female |
| Brennan Freeman | Vice President of Finance, Principal Accounting Officer & Corporate Controller | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NOTVQ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
